🇯🇵 Tresiba in Japan

PMDA authorised Tresiba on 28 September 2012

Marketing authorisation

PMDA — authorised 28 September 2012

  • Marketing authorisation holder: Novo Nordisk Pharma Ltd
  • Status: approved

Tresiba in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Tresiba approved in Japan?

Yes. PMDA authorised it on 28 September 2012.

Who is the marketing authorisation holder for Tresiba in Japan?

Novo Nordisk Pharma Ltd holds the Japanese marketing authorisation.